UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist

European journal of pharmacology, 2015-08, Vol.761, p.226-234

2015

Volltextzugriff (PDF)

Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model

Journal of the American Society of Nephrology, 2003-05, Vol.14 (5), p.1212-1222

2003

Volltextzugriff (PDF)

Spironolactone, but not Eplerenone, Impairs Glucose Tolerance in a Rat Model of Metabolic Syndrome

Journal of Veterinary Medical Science, 2012, Vol.74(8), pp.1015-1022

2012

Volltextzugriff (PDF)

A sensitive short-term evaluation of antifibrotic effects using newly established type I collagen reporter transgenic rats

American journal of physiology. Renal physiology, 2010-10, Vol.299 (4), p.F792-F801

2010

Volltextzugriff (PDF)

Renoprotective Effects of Blockade of Angiotensin II AT1 Receptors in an Animal Model of Type 2 Diabetes

Hypertension Research, 2002, Vol.25(2), pp.271-278

2002

Volltextzugriff (PDF)

In vitro and in vivo pharmacology of olmesartan medoxomil, an angiotensin II type AT1 receptor antagonist

Journal of hypertension, 2001-06, Vol.19 Suplement 1 (1), p.S3-S14

2001

Volltextzugriff (PDF)

Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist

European journal of pharmacology, 1995-10, Vol.285 (2), p.181-188

1995

Volltextzugriff (PDF)

R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model

European journal of pharmacology, 2014-07, Vol.734, p.60-66

2014

Volltextzugriff (PDF)

Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model of chronic cardiorenal syndrome

American journal of physiology. Renal physiology, 2012-03, Vol.302 (6), p.F750-F761

2012

Volltextzugriff (PDF)

Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model of chronic cardiorenal syndrome

American journal of physiology. Renal physiology, 2012, Vol.71 (3)

2012

Volltextzugriff (PDF)

A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic rats

Arteriosclerosis, thrombosis, and vascular biology, 2008-10, Vol.28 (10), p.1767-1773

2008

Volltextzugriff (PDF)

The Effect of Angiotensin II Receptor Blockade on an End-Stage Renal Failure Model of Type 2 Diabetes

Journal of cardiovascular pharmacology, 2006-10, Vol.48 (4), p.135-142

2006

Volltextzugriff (PDF)

PDGF-BB decreases systolic blood pressure through an increase in macrovascular compliance in rats

American journal of physiology. Heart and circulatory physiology, 1997-10, Vol.273 (4), p.H1719-H1726

1997

Volltextzugriff (PDF)

A sensitive short-term evaluation of antifibrotic effects using newly established type I collagen reporter transgenic rats

American journal of physiology. Renal physiology, 2010, Vol.68 (4)

2010

Volltextzugriff (PDF)

Effects of Angiotensin AT1 Receptor Antagonist on Volume Overload-Induced Cardiac Gene Expression in Rats

Hypertension Research, 1997, Vol.20(2), pp.133-142

1997

Volltextzugriff (PDF)

Pharmacological profiles and clinical effects of olmesartan medoxomil, a novel angiotensin II receptor blocker

Folia Pharmacologica Japonica, 2004, Vol.124(4), pp.257-269

2004

Volltextzugriff (PDF)

Pharmacological profiles and clinical effects of azelnidipine, a long-acting calcium channel blocker

Folia Pharmacologica Japonica, 2003, Vol.122(6), pp.539-547

2003

Volltextzugriff (PDF)

Severity of Hyperlipidemia Does Not Affect Antiatherosclerotic Effect of an Angiotensin II Receptor Antagonist in Apolipoprotein E-deficient Mice

Journal of cardiovascular pharmacology, 2006-06, Vol.47 (6), p.764-769

2006

Volltextzugriff (PDF)

Effect of Combined Treatment With an Angiotensin II Receptor Antagonist and an HMG-CoA Reductase Inhibitor on Atherosclerosis in Genetically Hyperlipidemic Rabbits

Journal of cardiovascular pharmacology, 2005-10, Vol.46 (4), p.556-562

2005

Volltextzugriff (PDF)

Nonpeptide Angiotensin II Receptor Antagonists: Synthesis, Biological Activities, and Structure−Activity Relationships of Imidazole-5-carboxylic Acids Bearing Alkyl, Alkenyl, and Hydroxyalkyl Substituents at the 4-Position and Their Related Compounds

Journal of medicinal chemistry, 1996-01, Vol.39 (1), p.323-338

1996

Volltextzugriff (PDF)

Angiotensin II receptor antagonists: imidazoles and pyrroles bearing hydroxymethyl and carboxy substituents

Bioorganic & medicinal chemistry letters, 1994-01, Vol.4 (1), p.177-182

1994

Volltextzugriff (PDF)

Cytosolic Free Calcium of Aorta in Hypertensive Rats Chronic Inhibition of Angiotensin Converting Enzyme

Hypertension (Dallas, Tex. 1979), 1990-09, Vol.16 (3), p.245-251

1990

Volltextzugriff (PDF)

Negative Chronotropic Effect of Endothelin 1 Mediated Through ET A Receptors in Guinea Pig Atria

Circulation research, 1995-02, Vol.76 (2), p.284-292

1995

Volltextzugriff (PDF)

Negative Chronotropic Effect of Endothelin 1 Mediated Through ETA Receptors in Guinea Pig Atria

Circulation research, 1995-02, Vol.76 (2), p.284-292

1995

Volltextzugriff (PDF)

Two N-terminally truncated forms of C-type natriuretic peptide from habu snake venom

Peptides (New York, N.Y. : 1980), 2000-05, Vol.21 (5), p.609-615

2000

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(88)
Berichte
(1)

Sprache

Englisch
(78)
Japanisch
(43)

Erscheinungsjahr

n.n

Thema

Science & Technology
(40)
Life Sciences & Biomedicine
(37)
Animals
(35)
Male
(28)
Rats
(25)
Biological And Medical Sciences
(19)
Pharmacology & Pharmacy
(18)
Medical Sciences
(15)
Blood Pressure - Drug Effects
(14)
Pharmacology. Drug Treatments
(14)
Cardiovascular System
(12)
Imidazoles - Pharmacology
(11)
In Vitro Techniques
(11)
Cardiovascular System & Cardiology
(10)
Olmesartan Medoxomil
(10)
Antihypertensive Agents
(9)
Humans
(9)
Tetrazoles - Pharmacology
(9)
Antihypertensive Agents - Pharmacology
(8)
Rats, Inbred Shr
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist

Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model

Spironolactone, but not Eplerenone, Impairs Glucose Tolerance in a Rat Model of Metabolic Syndrome

A sensitive short-term evaluation of antifibrotic effects using newly established type I collagen reporter transgenic rats

Renoprotective Effects of Blockade of Angiotensin II AT1 Receptors in an Animal Model of Type 2 Diabetes

In vitro and in vivo pharmacology of olmesartan medoxomil, an angiotensin II type AT1 receptor antagonist

Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist

R-268712, an orally active transforming growth factor-β type I receptor inhibitor, prevents glomerular sclerosis in a Thy1 nephritis model

Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model of chronic cardiorenal syndrome

Activation of renal angiotensin type 1 receptor contributes to the pathogenesis of progressive renal injury in a rat model of chronic cardiorenal syndrome

A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic rats

The Effect of Angiotensin II Receptor Blockade on an End-Stage Renal Failure Model of Type 2 Diabetes

PDGF-BB decreases systolic blood pressure through an increase in macrovascular compliance in rats

A sensitive short-term evaluation of antifibrotic effects using newly established type I collagen reporter transgenic rats

Effects of Angiotensin AT1 Receptor Antagonist on Volume Overload-Induced Cardiac Gene Expression in Rats

Pharmacological profiles and clinical effects of olmesartan medoxomil, a novel angiotensin II receptor blocker

Pharmacological profiles and clinical effects of azelnidipine, a long-acting calcium channel blocker

Severity of Hyperlipidemia Does Not Affect Antiatherosclerotic Effect of an Angiotensin II Receptor Antagonist in Apolipoprotein E-deficient Mice

Effect of Combined Treatment With an Angiotensin II Receptor Antagonist and an HMG-CoA Reductase Inhibitor on Atherosclerosis in Genetically Hyperlipidemic Rabbits

Nonpeptide Angiotensin II Receptor Antagonists: Synthesis, Biological Activities, and Structure−Activity Relationships of Imidazole-5-carboxylic Acids Bearing Alkyl, Alkenyl, and Hydroxyalkyl Substituents at the 4-Position and Their Related Compounds

Angiotensin II receptor antagonists: imidazoles and pyrroles bearing hydroxymethyl and carboxy substituents

Cytosolic Free Calcium of Aorta in Hypertensive Rats Chronic Inhibition of Angiotensin Converting Enzyme

Negative Chronotropic Effect of Endothelin 1 Mediated Through ET A Receptors in Guinea Pig Atria

Negative Chronotropic Effect of Endothelin 1 Mediated Through ETA Receptors in Guinea Pig Atria

Two N-terminally truncated forms of C-type natriuretic peptide from habu snake venom

Suchergebnisse filtern